Myotherix
WebMyotherix, Inc. Headquarters 29540 Kohoutek Way Union City, California94587 1-857-222-4653 Driving Directions » Myotherix, Inc. Summary ABOUT Overview Myotherix focuses on developing therapies for patients suffering from Duchenne muscular dystrophy and muscle disorders. Myotherix, Inc. was founded in 2013. WebGiles Campion works at Myotherix, which is a Business Services company. Giles is currently based in Union City, California. Found email listings in clude: @myotherix.com. Read More. Contact. Giles Campion's Phone Number and Email. Last Update. 9/4/2024 11:09 AM. Email. g***@myotherix.com. Engage via Email.
Myotherix
Did you know?
WebJan 2, 2024 · Dr. Michael G. Kelly is a senior pharmaceutical executive with more than thirty years of achievement setting business strategies in building and managing drug discovery … WebSoterix Medical is the world leader in non-invasive neuromodulation and brain stimulation technology. Researchers and clinicians choose Soterix Medical devices and accessories …
WebDigital Healthcare Portal. Empowering patients with transparent healthcare. services, simple scheduling, and real-time feedback. Supporting physicians with telemedicine tools, … WebCo-Founder and Executive Chairman Dr. de Souza has deep experience in creating and developing virtual biotechnology companies. He has participated as a CEO/Executive Chairman/Co-Founder of NFlection Therapeutics, Chromaderm, SeylanMed, PellePharm, MyoTherix, Lotus Tissue Repair, and others.
WebMyoTherix is a clinical-stage drug discovery and development company for patients suffering from rare neuromuscular disorders. WebJun 21, 2024 · Anti-Inflammatory Therapy Anti-Fibrosis Therapy Mitochondrial Cardiac Function Muscle Regeneration Muscle Stabilization Cell Therapy * Discontinued means Discontinued at the clinical stage Last Updated 6/21/2024 Share This Page Make an Impact You can advance the care, treatment and cure for Duchenne muscular dystrophy.
WebJohn Kincaid is the Director, Co-Founder at MyoTherix. MyoTherix Director, Co-Founder. Related Hubs. Edit Related Hubs Section. Hub Name . CB Rank (Hub) Health Diagnostics Companies With Fewer Than 10 Employees . 15,963: Recent News and Activity. Edit Recent News and Activity Section.
WebSearch our free database to find email addresses and direct dials for Myotherix employees. the seaward innWebApr 16, 2024 · LONDON, Silence Therapeutics plc (LON: SLN) (“Silence” or “the Company”) a leader in the discovery, development and delivery of novel RNA therapeutics for the treatment of serious diseases, is pleased to announce the appointment of Giles Campion, MD as Head of R&D and Chief Medical Officer, effective 1 June 2024. the seaward hotel weston super mareWebSep 1, 2015 · MyoTherix, Inc. is a venture-supported biotechnology company focused on developing novel therapeutics for the treatment of muscle disorders. Its lead product opportunity utilizes an innovative and novel approach to target both cardiac and skeletal muscle weakness. my pillow sheets saleWebLooking for a credit report on Myotherix, Inc.? Our Business Information Report Snapshot is a collection of business credit scores and ratings that help you gauge the financial health … my pillow shopWebInc. Myotherix has a registered in the System for Award Management for doing business with and bidding for contracts by the United States government. Cage Code 72CN4 was listed as their unique company identifier. The company registered with SAM on 2013-12-04 and the registration with the below details. Company Details my pillow sightWebMyoTherix's President & CEO, Director, Co-Founder is Michael G. Kelly. Other executives include John Kincaid, Director, Co-Founder; Mark P. de Souza, COO, Director, Co-Founder and 1 others. See the full leadership team at Craft. my pillow siteWebNEWPORT BEACH, Calif., September 1, 2015 – CureDuchenne Ventures LLC, a company that funds research to find a cure for Duchenne muscular dystrophy, announced today that they have invested $1 million in MyoTherix Inc., a biotechnology company focused on developing novel therapeutics for the treatment of Duchenne and other muscular dystrophies. the seaway provide